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http://dx.doi.org/10.1016/j.jfma.201Background/Purpose: Health-related quality of life (HRQOL) is considered an important
outcome indicator in substances abuse studies. However, psychometric properties of HRQOL
measures are largely unknown in people who abuse heroin. Therefore, the present study aimed
to examine data quality, scaling properties, reliability, and construct validity of the 36-Item
Short Form healthy survey (SF-36) in people who abuse heroin.
Methods: A total of 469 people who abuse heroin participated in the study. Data quality was
determined by data completeness. Scaling properties were evaluated by item frequency distri-
bution, equivalence of item means and standard deviations, item-internal consistency, and
item-discriminant validity (calculating scaling success). Internal consistency was examined
using Cronbach’s a. Construct validity was examined by investigating convergent validity
and divergent validity among the eight scales of the SF-36.
Results: The results of data quality showed low missing rates (0.0e3.8%) and high comple-
tion rates in the scales (91.9e98.7%). The results of scaling assumptions showed good item
frequency distribution on each item, roughly equivalent item means and standard devia-
tions within a scale, good item-internal consistency (>0.4) and good scaling success rates
(77.5e100%), except on the two scales of bodily pain (BP) and social functioning (SF).
Three scales showed ceiling and/or floor effects [i.e., physical functioning (PF), role limi-
tations due to physical problems (RP), and role limitations due to emotional problemshave no conflicts of interest relevant to this article.
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Psychometric properties of SF-36 235(RE)]. Cronbach’s a was acceptable (>0.7), except for the BP and SF scales. Construct va-
lidity was partially supported by the results of convergent validity and divergent validity.
Conclusion: The results confirmed good data quality; satisfactory scaling assumptions and
internal consistency (except for the BP and SF scales); and generally acceptable construct
validity. However, the PF, RP, and RE scales showed ceiling and/or floor effects. Therefore,
the BP, SF, PF, RP, and RE scales should be used with cautions in measuring HRQOL in
people who abuse heroin.
Copyright ª 2012, Elsevier Taiwan LLC & Formosan Medical Association. All rights reserved.Introduction
Heroin is the most commonly abused of the opioid drugs.1
People who abuse heroin are at the risk of having physical
complications, especially HIV, hepatitis B, and hepatitis C
infection.2e4 The cost of medical care, lost productivity,
crime and social welfare due to people who abuse heroin
pose a large economic burden to society.5 Assessing the
conditions of people who abuse heroin and monitoring their
progress are mandatory for planning the treatment inter-
ventions and promoting health care.
Health-related quality of life (HRQOL) is an important
outcome indicator in treatment studies and health service
evaluations in people who abuse heroin.6,7 HRQOL is
a multidimensional construct reflecting an individual’s
health functions, such as physical health, psychological
state, and social relationship.8 People who abuse heroin are
liable to experience (1) physical illness, such as skin and
soft tissue infection, cardiac disease, and respiratory dis-
ease;1,9e11 (2) psychiatric symptoms, including depression
or anxiety;1 and (3) poor social relationship.12 The above-
mentioned HRQOL in people who abuse heroin need to be
assessed comprehensively for clinical reasoning, treatment
planning, and application as outcome measures.
Previous studies have used HRQOL measures in people
who abuse heroin or drug abusers. Some generic HRQOL
measures [e.g., the 36-Item Short Form healthy survey
(SF-36), the World Health Organization Quality of Life Scale
Brief Version (WHOQOL-BREF), the Nottingham health
profile, and the EuroQol Quality of Life Scale (EQ-5D)],12e15
or some disease-specific HRQOL measures (e.g., the
Lancashire Quality of Life Profile, and the Quality of Life
Enjoyment and Satisfaction Questionnaire) have been
employed.13,16,17 Compared with other measures, the SF-36
is most commonly used in studies of people with heroin
abuse or drug abuse. The eight scales of the SF-36 measure
the main health issues of people who abuse heroin (i.e.,
physical illness, psychiatric symptoms, and social relation-
ships). In addition, the SF-36 is a generic HRQOL measure,
which can render results for comparing HRQOL between
populations. Therefore, the SF-36 appears to be adequate
for people who abuse heroin.
When a measure is used in a specific group, it is neces-
sary to check of psychometric properties of the measure in
that group.18 Data quality, scaling assumptions, reliability,
and construct validity are important psychometric proper-
ties of a measure.19 Data quality indicates the item
nonresponse and missing scale scores, which reflects
examinees’ understanding and acceptance of the items.
Scaling assumptions determine whether items are assem-
bled as a same construct within a scale, indicating items ofa scale can be summed without weights to generate scale
scores.19 Reliability shows that the results of a measure are
consistent, stable over time, and reproducible.20 Internal
consistency, one type of reliability, demonstrates the
consistency of the results across items of a measure.21
Construct validity reflects the degree to which the inten-
ded theoretical constructs are measured.22 These above-
mentioned psychometric properties are important for
a measure to be used in both clinical and research settings.
The data quality, scaling assumptions, reliability, and
construct validity of the SF-36 have been investigated in
healthy people or patient samples.23e25 These psychometric
properties of the SF-36 have been examined in a healthy
population in Taiwan.26 For that population, the results were
lowmissing rates; good item-internal consistency, except for
the PF and SF scales; good scaling success rates, except for
the SF scale; acceptable internal consistency, except for the
BP and SF scales; and acceptable construct validity.26
However, the psychometric properties of a questionnaire
are sample dependent and need to be validated in any
sample to which the questionnaire will be applied.27 To our
knowledge, no study has examined these psychometric
properties of the SF-36 in people with heroin abuse. There-
fore, the study aimed to examine the data quality, scaling
assumptions, internal consistency, and construct validity of
this measure in people who abuse heroin.Methods
Participants
Participants of this study were recruited from the registry of
theMethadoneMaintenanceTreatment Study at theTaoyuan
Veterans Hospital in Taiwan between April 2004 and August
2008. The Methadone Maintenance Treatment Study was
a prospective cohort study. The study was approved by the
Institutional Review Board of the local hospital. The
following criteria were used to recruit the participants: (1)
age from 20 to 65 years; (2) diagnosis of heroin dependence
based on DSM-IV criteria; (3) multiple self-administrations of
heroin for 1 year or more; (4) positive urine test result for
heroin earlier than 1e3 months prior to taking methadone;
(5) informed consent for participation obtained from the
participant; (6) ability to complete the necessary examina-
tion andassessment; and (7) residence in the counties nearby
the hospital for follow-up.
Four exclusion criteria were chosen in this study. The
first exclusion criterion was having high suicide risk, which
may prevent participants from completing a long-term
follow-up study (the Methadone Maintenance Treatment).
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agents and antiepileptic drugs, which may influence the
efficacy of the methadone. The third exclusion criterion
was having a history of seizure that might be caused by
taking methadone. The fourth exclusion criterion was
having a severe or unstable disease that may be aggravated
by taking methadone, such as cancer, stroke, angina pec-
toris, myocardial infarction, heart failure, or chronic
obstructive pulmonary disease.
Procedures
The participants were enrolled in the Methadone Mainte-
nance Treatment Study at their first meeting with psychi-
atrists. During the same session, they signed the informed
consent, filled out a demography questionnaire, and
completed the self-administered SF-36 health survey.
Psychiatrists provided methadone maintenance treatment
whether or not the SF-36 was completed.
Instrument
The SF-36 health survey contains 36 items.28 One item is
designed to assess the health transition during the previous
year [reported health transition (RT)], and the others are
divided into eight multi-item scales, including physical
functioning (PF; 10 items, rated from 1e3), role limitations
due to physical problems (RP; four items, rated from 1e2),
bodily pain (BP; two items, rated from 1e6 or 1e5), general
health perceptions (GH; five items, rated from 1e5),
vitality (VT; four items, rated from 1e6), social functioning
(SF; two items, rated from 1e5), role limitations due to
emotional problems (RE; three items, rated from 1e2), and
mental health (MH; five items, rated from 1 to 6). For each
scale, its score is transformed into a score of 0e100
following the standard SF-36 scoring algorithms. A higher
score represents better health status.28 The SF-36 Taiwan
version29 was used in this study.
Data analysis
Data quality indicates data completeness by participants at
both item and scale levels. Data completeness was exam-
ined by analyzing the percentage of missing data for each
item, the percentage having complete data for each scale,
and the percentage of participants for whom scale scores
could be computed utilizing standard SF-36 scoring algo-
rithms.30 If an examinee did not answer at least 50% of the
items in a scale, then the scale score was not calculated
and regarded as a missing score. If there is a large amount
of missing data, then a summated rating score cannot be
achieved.31 Missing data for each item of less than 10% was
considered as acceptable.19
Scaling assumptions were tested by the summated-
rating method,23 including item frequency distribution,
equivalence of item means and standard deviations, item-
internal consistency, and item-discriminant validity. The
testing of scaling assumptions is useful to determine
whether the item scores of a scale can be summated. Item
frequency distribution was analyzed to ascertain whether
all of the response choices were used. Item means andstandard deviations should be roughly equivalent within
a scale. The score distribution of the scales with equivalent
item means was analyzed to check whether there was
a high percentage of the participants on a possible score
(including both extreme scores, i.e., floor and ceiling
effects). If there was a high percentage (20%) of the
participants scoring on a particular score of a scale, then
the discriminative ability of the scale was threatened.32
Item-internal consistency was evaluated by examining the
correlation between an item and its hypothesized scale.
The item-scale correlation was corrected for overlap,
which meant estimating the correlation between the item
and the sum of all other items in the same scale. The
criterion of item-internal consistency was >0.40.33
Item-discriminant validity was identified if the correla-
tion between an item and hypothesized scale was signifi-
cantly higher than the correlations between the particular
item and all other scales. The significant level for
comparing two correlations was two standard errors. The
standard error was calculated as 1 divided by the square
root of the sample size. Item-discriminant validity was
ascertained, and then a definite scaling success was noted.
Scaling success rate was estimated as the percentage of
item-scale correlations significantly higher for the hypoth-
esized scale than for the competing scale.30,33,34
Internal consistency was investigated using Cronbach’s
alpha (a). The criterion of reliability coefficient for group
level comparisons was >0.7, and the criterion for individual
level comparisons was >0.9.35
Construct validity was examined by investigating
convergent validity and divergent validity among the eight
scales of the SF-36. These qualities of the eight scales of
the SF-36 were examined using Pearson’s r. A moderate to
strong correlation between the scales (0.30 < r < 0.70
indicating moderate correlation; r  0.70 indicating strong
correlation) represented sufficient convergent validity.36 A
low correlation between the scales (r  0.30) indicated
sufficient divergent validity.36 To examine convergent val-
idity, we assumed moderate to strong correlations among
the four physical health-related scales (i.e., the PF, RP, BP,
and GH scales) and among the four mental health-related
scales (i.e., the VT, SF, RE, and MH scales).37 Moreover,
we assumed moderate to strong correlations between the
RP and RE scales because these two scales measured role
disability-related construct.36 To examine divergent val-
idity, we assumed low correlations between the PF and MH
scales, between the PF and RE scales, and between the RP
and MH scales. These hypotheses for divergent validation
were based on the fact that the PF and RP scales primarily
measure physical health rather than mental health, and the
MH and RE scales primarily measure mental health rather
than physical health.36Results
A total of 469 participants completed the SF-36. Their ages
ranged from20 to 60 years. More than half of themwere aged
from30 to 39 years, andmore than one-half of themwere not
married. Three quarters of the participants were men. Most
participants had received 9e12 years of education. Further
details of the participants are listed in Table 1.
Table 1 Patient characteristics.
N Z 469
Sex
Male 77.4%
Female 22.6%
Age (y)
20e29 22.4%
30e39 50.7%
40e49 22.6%
50e60 4.3%
Marital status
Single 54.6%
Married 22.2%
Remarried 0.2%
Separated 1.1%
Divorced 21.9%
Education
Elementary school 6.2%
Junior high school 42.8%
Senior high school 46.5%
College 4.5%
Other diseases
Hepatitis B 10.2%
Hepatitis C 23.9%
HIV 5.3%
Method of taking heroina
Intravenous use 82.8%
Intramuscular use 7.2%
Inhalation 13.5%
Religion
No 22.1%
Buddhism 56.0%
Christianity 6.4%
Catholicism 0.9%
Taoism 14.4%
Others 0.2%
Working hours
0 39.8%
<20 12.3%
20e40 12.3%
>40 35.6%
Financial support
Yes 43.3%
No 56.7%
a A participant could use more than one method to take
heroin.
Table 2 Item frequency distribution and percentage of
missing data (N Z 469).
Scale Item Item frequency distribution
percentage in each category
Missing
data (%)
1 2 3 4 5 6
PF 1 14.6 49.4 36.0 d d d 3.4
2 6.4 37.7 55.9 d d d 3.8
3 4.8 27.9 67.3 d d d 2.8
4 7.4 41.6 51.0 d d d 2.6
5 3.9 21.3 74.8 d d d 2.8
6 5.5 25.1 69.5 d d d 3.0
7 8.5 40.9 50.5 d d d 2.6
8 6.4 29.8 63.8 d d d 2.8
9 4.4 17.7 77.9 d d d 2.6
10 3.3 13.3 83.4 d d d 2.1
RP 1 58.4 41.6 d d d d 2.6
2 60.0 40.0 d d d d 2.3
3 49.3 50.7 d d d d 2.8
4 52.8 47.2 d d d d 2.3
BP 1a 4.3 6.2 20.9 24.5 18.1 26.0 0.9
2a 0.2 40.8 16.9 10.0 4.3 27.8 1.7
GH 1a 15.0 40.1 16.7 22.3 5.8 d 0.6
2 15.1 19.5 31.7 17.1 16.6 d 2.6
3a 10.9 24.4 29.4 24.4 10.9 d 2.1
4 26.2 27.1 24.7 11.6 10.5 d 2.3
5a 15.2 24.6 27.9 21.1 11.2 d 3.0
VT 1a 3.3 29.9 40.2 8.7 10.7 7.2 2.3
2a 5.8 30.3 41.2 10.6 6.9 5.3 3.6
3 4.6 9.9 20.0 41.9 18.4 5.3 2.8
4 9.4 11.1 24.6 40.7 7.6 6.5 2.1
SF 1a 3.2 11.6 12.2 39.5 33.5 d 0.6
2 15.2 19.7 39.7 18.2 7.1 d 0.6
RE 1 63.2 36.8 d d d d 2.1
2 60.6 39.3 d d d d 3.2
3 63.4 36.6 d d d d 3.2
MH 1 6.9 8.4 17.3 39.5 21.7 6.2 3.8
2 5.5 8.8 21.1 38.2 20.6 5.9 2.8
3a 5.0 28.3 39.5 12.9 8.6 5.7 2.8
4 6.0 10.4 24.8 37.0 16.2 5.5 3.8
5a 7.0 25.7 36.8 12.7 9.9 7.9 2.8
RT 1 21.5 34.8 32.0 7.0 4.7 d 0.0
d indicates no possible response for the level.
BP Z bodily pain; GH Z general health perceptions;
MH Z mental health; PF Z physical functioning; RE Z role
limitations due to emotional problems; RP Z role limitations
due to physical problems; RT Z reported health transition;
SF Z social functioning; VT Z vitality.
a Item recoded. High scores indicate good health.
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rates on item level ranged from 0.0% (RT) to 3.8% (PF2,
MH1, and MH4), averaging 2.4% (<10%). These data are
shown in Table 2. The percentage of obtaining complete
data on scale level ranged from 91.9% (PF) to 98.7%
(SF). The percentage of participants whose scores were
calculated for further analysis ranged from 96.6% (RE) to
100% (SF).The results of item frequency distributions demon-
strated that all of the response choices on the eight scales
were used (Table 2). Comparing all items means and stan-
dard deviations within their hypothesized scales, the item
means and standard deviations of the PF, RP, GH, RE scales
were approximately equivalent (Table 3). The item means
of the BP and SF scales were different within their scales.
Ceiling effects were observed in the PF, RP, and RE scales
(26.7%, 30.6%, and 29.4%, respectively). Floor effects were
found in the RP and RE scales (39.8% and 52.5%,
Table 3 Item means, SDs, and item-scale correlations (N Z 469).
Scale Item Mean SD Item-scale correlation
PF RP BP GH VT SF RE MH RT
PF 1 2.21 0.68 0.62 0.42 0.34 0.34 0.32 0.39 0.38 0.31 0.24
2 2.50 0.62 0.72 0.44 0.33 0.30 0.31 0.35 0.36 0.26 0.20
3 2.63 0.58 0.79 0.41 0.31 0.29 0.25 0.30 0.31 0.21 0.19
4 2.44 0.63 0.75 0.42 0.35 0.34 0.35 0.36 0.37 0.27 0.21
5 2.71 0.54 0.74 0.35 0.26 0.24 0.20 0.31 0.25 0.17 0.13
6 2.64 0.58 0.75 0.40 0.28 0.26 0.22 0.34 0.30 0.17 0.15
7 2.42 0.64 0.74 0.39 0.29 0.36 0.28 0.35 0.34 0.24 0.23
8 2.57 0.61 0.81 0.42 0.29 0.31 0.29 0.35 0.36 0.23 0.20
9 2.74 0.53 0.77 0.37 0.24 0.24 0.18 0.29 0.28 0.15 0.13
10 2.80 0.47 0.63 0.35 0.23 0.16 0.15 0.22 0.26 0.14 0.17
RP 1 1.42 0.49 0.40 0.79 0.38 0.39 0.39 0.43 0.66 0.38 0.27
2 1.40 0.49 0.39 0.77 0.36 0.40 0.39 0.37 0.67 0.32 0.28
3 1.51 0.50 0.48 0.74 0.39 0.43 0.44 0.46 0.58 0.39 0.29
4 1.47 0.50 0.50 0.75 0.43 0.46 0.44 0.45 0.65 0.37 0.32
BP 1 4.40 1.42 0.37 0.41 0.24 0.45 0.47 0.49 0.40 0.36 0.34
2 3.61 1.68 0.23 0.31 0.24 0.24 0.23 0.21 0.36 0.22 0.18
GH 1 2.78 1.31 0.31 0.36 0.34 0.45 0.48 0.39 0.34 0.39 0.52
2 2.99 1.29 0.35 0.39 0.32 0.55 0.38 0.41 0.34 0.44 0.30
3 2.99 1.17 0.23 0.31 0.27 0.54 0.48 0.35 0.28 0.48 0.31
4 2.53 1.29 0.23 0.38 0.30 0.57 0.42 0.37 0.38 0.43 0.32
5 2.86 1.24 0.21 0.32 0.33 0.68 0.50 0.40 0.31 0.50 0.37
VT 1 3.13 1.28 0.18 0.30 0.31 0.41 0.50 0.36 0.35 0.49 0.35
2 2.94 1.23 0.21 0.32 0.31 0.44 0.56 0.39 0.33 0.55 0.34
3 3.73 1.20 0.32 0.43 0.35 0.52 0.58 0.49 0.40 0.67 0.31
4 3.46 1.26 0.30 0.40 0.35 0.50 0.59 0.45 0.40 0.66 0.33
SF 1 3.86 1.14 0.38 0.44 0.41 0.47 0.50 0.36 0.45 0.48 0.40
2 2.80 1.13 0.31 0.36 0.30 0.40 0.42 0.36 0.32 0.47 0.22
RE 1 1.37 0.48 0.40 0.69 0.45 0.43 0.44 0.46 0.82 0.44 0.32
2 1.39 0.49 0.38 0.68 0.43 0.41 0.44 0.43 0.80 0.38 0.33
3 1.37 0.48 0.35 0.64 0.42 0.40 0.45 0.40 0.77 0.43 0.28
MH 1 3.71 1.35 0.19 0.31 0.21 0.36 0.41 0.41 0.31 0.49 0.18
2 3.75 1.25 0.25 0.38 0.32 0.46 0.58 0.46 0.39 0.64 0.28
3 3.07 1.23 0.16 0.25 0.27 0.42 0.57 0.36 0.28 0.45 0.34
4 3.57 1.29 0.25 0.32 0.26 0.53 0.64 0.43 0.36 0.63 0.30
5 3.14 1.34 0.16 0.28 0.26 0.46 0.63 0.42 0.31 0.53 0.36
RT 1 2.39 1.05 0.25 0.35 0.32 0.51 0.44 0.36 0.35 0.41
Item-scale correlations in bold denote correlations corrected for overlap.
BP Z bodily pain; GH Z general health perceptions; MH Z mental health; PF Z physical functioning; RE Z role limitations due to
emotional problems; RP Z role limitations due to physical problems; RT Z reported health transition; SF Z social functioning;
VT Z vitality.
238 E.-C. Chiu et al.respectively). The GH, VT, and MH scales did not show
a high percentage of the participants on any possible score.
Item-internal consistency of each item was >0.4, except
those of the items in the BP and SF scales (Table 3). Item-
internal consistency of each item was similar to the other
items in its hypothesized scale. For example, item-internal
consistencies of RP1-RP4 were 0.74e0.79. Item-internal
consistencies of items PF1, PF10, and GH1 were 0.62,
0.63, and 0.45, respectively. These values were lower than
those of the other items in their hypothesized scales (those
of the other items of the PF scale were 0.72e0.81 and of
the other items of the GH scale were 0.54e0.68).
Item-discriminant validity of the PF, RP, and RE scales
showed that the correlation between an item and its
hypothesized scale was significantly higher than thecorrelation between that item and other scales (Table 4).
Item-internal consistencies of the PF scale were
0.62e0.81, higher than item-discriminant validities of the
PF scale of 0.13e0.44. Item-internal consistencies of the
RP scale were 0.74e0.79, higher than item-discriminant
validities of the RP scale of 0.27e0.67. Item-internal
consistencies of the RE scale were 0.77e0.82, higher
than item-discriminant validities of the RE scale of
0.28e0.69. Therefore, the scaling success rates of these
three scales were 100%. The scaling success rates of the
GH, VT, and MH were approximately 80%. However, the
scaling success rates of the BP and SF were as low as 0%
and 6.3%, respectively.
Cronbach’s a of the RP, GH, VT, and MH scales exceeded
the criterion of 0.7 for group comparisons (Table 4).
Table 4 Results of item-scaling tests and reliability estimates (N Z 469).
Scale Number of items Range of item-scale correlations Item scaling tests Reliabilityd
(Cronbach’s a)
Cronbach a
(if an item
was deleted)e
Item-internal
consistencya
Item-discriminant
validityb
Success
totalc
Scaling
success (%)
PF 10 0.62e0.81 0.13e0.44 80/80 100 0.93 0.92e0.93
RP 4 0.74e0.79 0.27e0.67 32/32 100 0.89 0.85e0.87
BP 2 0.24 0.18e0.49 0/16 0 0.38 d
GH 5 0.45e0.68 0.21e0.52 33/40 82.5 0.78 0.70e0.78
VT 4 0.50e0.59 0.18e0.67 26/32 81.3 0.76 0.68e0.73
SF 2 0.36 0.22e0.50 1/16 6.3 0.53 d
RE 3 0.77e0.82 0.28e0.69 24/24 100 0.90 0.83e0.87
MH 5 0.45e0.64 0.16e0.64 31/40 77.5 0.77 0.70e0.76
BP Z bodily pain; GH Z general health perceptions; MH Z mental health; PF Z physical functioning; RE Z role limitations due to
emotional problems; RP Z role limitations due to physical problems; RT Z reported health transition; SF Z social functioning;
VT Z vitality.
a Correlations between items and hypothesized scale corrected for overlap.
b Correlations between items and the other scales.
c Number of definite scaling successes/total number of correlations.
d Internal consistency.
e No estimation for the scale having two items.
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recommended standard 0.9 criterion for individual
comparisons. Cronbach’s a of the PF, RP, GH, VT, RE, and
MH scales, if an item was deleted, was lower than the
scale’s original Cronbach’s a. However, Cronbach’s a of the
BP and SF scales were 0.38 and 0.53, respectively, lower
than the criterion for group comparisons.
Table 5 shows correlations of the eight scales under
investigation. For examination of convergent validity,
moderate correlations (r Z 0.36e0.51) were found among
the 4 physical health-related scales. Moderate to strong
correlations (r Z 0.44e0.78) were found among the 4
mental health-related scales. Strong correlation (r Z 0.74)
was found between the RP and RE scales. For examination
of divergent validity, there was a low correlation (rZ 0.28)
between the PF and MH scales. Moderate correlations were
found between the PF and RE scales (r Z 0.41), and
between the RP and MH scales (r Z 0.41).Table 5 Correlations between scales of the SF-36 (Pear-
son r).
Scale PF RP BP VT SF RE
RP 0.51a
BP 0.38a 0.45a
GH 0.36a 0.47a 0.43a
SF d d d 0.55a
RE 0.41b 0.74a d 0.47a 0.45a
MH 0.28b 0.41b d 0.78a 0.54a 0.44a
d indicates that no appropriate hypotheses were made for
examining either divergent or convergent validity. BP Z bodily
pain; GH Z general health perceptions; MH Z mental health;
PF Z physical functioning; RE Z role limitations due to
emotional problems; RP Z role limitations due to physical
problems; RT Z reported health transition; SF Z social func-
tioning; VT Z vitality.
a Examination of convergent validity.
b Examination of divergent validity.Discussion
To test data quality of the SF-36, calculations of the
amount of data completeness evaluated whether the
participants could understand and accept the questions of
the SF-36, as well as whether they could complete the
questionnaire on their own. Findings showed a low missing
rate for each item (<4%), a high data completion rate
(>90%) in each scale, and a high computable scale scores
(>95%). The missing rate in this study was lower than or
similar to the results of psychometric testing of the SF-36
Taiwan version in the Taiwanese general population.29
Therefore, the test of data quality provided good results
for the participants in this study, indicating that the SF-36
can be self-administered in the heroin sample.
The present study used four indicators to examine
scaling assumptions of the SF-36. According to the results of
item frequency distribution, the response choices of each
item were all utilized, which indicated that the scale
descriptors could represent the conditions of people who
abuse heroin. The item means and standard deviations
were roughly equivalent within each scale, except those of
the BP and SF scales. The equivalence of item means and
standard deviations indicates that the distributions of the
items were the same within a scale; therefore, the scores
of the items can be summed up.19 However, if item means
were equivalent within a scale, the items may not be able
to discriminate the participants with various HRQOL. We
found ceiling and floor effects in the RP and RE scales,
indicating that these scales could not discriminate the
participants with high and low HRQOL. We found the ceiling
effect in the PF scale, indicating that this scale could not
discriminate the participants with high HRQOL. The GH, VT,
and MH scales demonstrated no high percentage of the
participants on any possible score, indicating the discrimi-
native ability of the three scales. Briefly, six scales satisfied
with the scaling assumptions of item means and standard
deviations, but three of the six scales (i.e., the RP, RE, and
240 E.-C. Chiu et al.PF scales) could not discriminate participants with high
and/or low HRQOL.
The results showed that item-internal consistencies of
all scales were 0.45, except the BP and SF scales. The low
item-internal consistencies in the BP and SF scales indi-
cated that their items may not be substantially linearly
related to their underlying concepts in people who abuse
heroin.31 The items of the BP and SF scales may measure
different concepts. Hence, it may not be appropriate to
combine their items of BP and SF, respectively, to generate
the total scores for people who abuse heroin. Item-internal
consistencies of items PF1, PF10, and GH1 were lower than
those of the other items on their hypothesized scales,
which indicated that these three items contribute low
proportions of information to their corresponding
constructs.31 In theory, items on a scale may contain
roughly equal proportions of information about the
construct, if not, the items may be given different
weights.38 Therefore, the items PF1, PF10 and GH1 may be
considered to have larger weights in their hypothesized
scales39 in evaluating of people who abuse heroin. Further
studies are needed to clarify whether we need to give
weights on these three items in people who abuse heroin.
Item-discriminant validity was also investigated. We
found that most of items had higher correlations with their
hypothesized scales than with other scales, except the
items of the BP and SF scales. The scaling success rates for
the BP and SF scales were low. The items of the BP and SF
scales may not reflect their original constructs in the
people who abuse heroin.
The scales in the SF-36, except the BP and SF scales,
demonstrated acceptable internal consistency. Our findings
of internal consistency were not consistent with those of
studies in China,40 Hong Kong,41 and Thailand.25 The major
difference was Cronbach’s a of the BP scale (a < 0.7 in our
study; a > 0.7 in other studies).25,40,41 Two possible reasons
explain the difference. First, people living in different
countries have different perceptions of health and illness.
Second, the characteristics of the samples in our study were
different from those in the previous studies in these Asian
countries (e.g., elderly population or healthy population).
Thus, our findings showed that the interrelatedness of the
items of the BPand SF scales is not sufficient for research and
clinical application, at least in peoplewith peoplewho abuse
heroin in Taiwan. Additionally, Cronbach’s a for the PF, RP,
GH, VT, RE, and MH scales, with an item deleted, was lower
than the scale’s original Cronbach’s a, indicating that
each item has a unique contribution to improving the value
of internal consistency within its scale. Therefore, the
responses of people who abuse heroin generated consistent
answers to the items on these six scales.
Regarding convergent validity, moderate correlations
were found among the four physical health-related scales,
indicating that these scales showed sufficient convergent
validity. Moderate to strong correlations were found among
the four mental health-related scales, indicating that these
scales showed sufficient convergent validity. Strong corre-
lation between the RP and RE scales indicated that these
two scales showed sufficient convergent validity. Thus,
construct validity of the eight scales was supported by the
results of convergent validity. Regarding divergent validity,
correlation between the PF and MH scales was low,indicating that the PF and MH scales showed sufficient
divergent validity. However, moderate correlations were
found between the PF and RE scales, and between the RP
and MH scales. These findings indicated that the PF and RE
scales might not be two distinct constructs, and the RP and
MH scales were not distinct from each other. However, the
variance explained from each other (PF vs. RE; RP vs. MH)
was only modest (r2Z 0.17). Thus, further validation of the
construct assessed by the four scales is needed. In brief,
construct validity of the SF-36 was partially supported.
Further construct validation or application of different
methods (e.g., confirmatory factor analysis) is warranted.
One limitation of the present study was related to its
generalization. This study used a convenience sample.
Thus, we did not calculate the proportions of approaching
the subjects, agreeing to participate, the consent rate and
exclusion rate. Additionally, this study analyzed partici-
pants from only one hospital in Taiwan. Further studies
could compare our findings of the SF-36 with other heroin
samples from a range of communities to further validate
our findings. A second limitation was that more than half of
the participants were aged from 30 to 39 years. Further
studies may include more participants in different age
groups, and provide further validation of the findings. A
third limitation was that we calculated data completeness
to determine the understanding and acceptance of the
items among participants. However, the participants might
have completed the SF-36 with guesses if they did not fully
understand the items. Therefore, our findings of data
completeness might be overestimated. Further studies may
apply cognitive debriefing to assess respondents’ interpre-
tations of items of the SF-36 to determine whether the
participants understand the items. A fourth limitation was
that we did not examine test-retest reliability and
responsiveness of the SF-36, which may limit its utility of
repeated assessments in both clinical and research settings.
In summary, the findings of this study confirmed good
data quality; satisfactory scaling assumptions and internal
consistency (except for the BP and SF scales); and generally
acceptable construct validity. However, the PF, RP, and RE
scales showed ceiling and/or floor effects. Therefore, the
BP, SF, PF, RP, and RE scales should be used with cautions in
measuring HRQOL in people who abuse heroin.Acknowledgments
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